Álvaro Pinto· @dralvaropinto · X·· 2 天前评分70
正文 · 原文
KN-866: perioperative CisGem +/- Pembro in MIBC. No benefit in EFS/OS, slight increase in pCR. Big difference compared with NIAGARA. Which could be the reasons that explain these discordant results? #ESMO26
89 浏览 · 0 赞 · 0 转发 · 0 回复
来源：Álvaro Pinto · x.com